NCT03801733View on ClinicalTrials.gov

Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

June 17, 2018

Primary Completion Date

November 24, 2018

Study Completion Date

November 24, 2018

Conditions
Drug Interaction Potentiation
Interventions
DRUG

Vadadustat

Oral dose of 600 mg QD

DRUG

Simvastatin

Oral Simvastatin

DRUG

Rosuvastatin

Oral Rosuvastatin

DRUG

Atorvastatin

Oral Atorvastatin

DRUG

Pravastatin

Oral Pravastatin

DRUG

Sulfasalazine

Oral Sulfasalazine

Trial Locations (1)

G1P A02

InVentiv Health Clinique Inc., Québec

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY